Lv0
0 积分 2024-04-25 加入
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
2小时前
已完结
Killing Two Birds with One Stone: the Therapeutic Role of Ibrutinib in Schnitzler Syndrome
3个月前
已完结
A Novel Engineering Cell Therapy Platform Mimicking the Immune Thrombocytopenia‐Derived Platelets to Inhibit Cytokine Storm in Hemophagocytic Lymphohistiocytosis
4个月前
已完结
An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
4个月前
已完结
Case report: Successful treatment with tofacitinib and colchicine in a patient with Schnitzler syndrome
4个月前
已完结
Case report: Successful treatment with tofacitinib and colchicine in a patient with Schnitzler syndrome
4个月前
已完结
Development of novel humanized CD19/BAFFR bicistronic chimeric antigen receptor T cells with potent antitumor activity against B-cell lineage neoplasms
6个月前
已完结
How do we manage t(11;14) plasma cell disorders with venetoclax?
7个月前
已完结
Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria
8个月前
已关闭
Venetoclax in upfront induction therapy for primary plasma cell leukemia with t(11;14) or BCL2 expression
8个月前
已完结
皖公网安备34019202002308
